Stock Events

Stock Events

Denali Therapeutics (D2NL34.SA) Q2 2024 Earnings

7MayConfirmed

Q4 2023

Q2 2024

-4.24

-3.98

-3.71

-3.45

Details

Expected EPS

-3.5255579291999997

Actual EPS

-3.449844

Surprise EPS

0.08

Surprise Percent

+2.15%

Description

Denali Therapeutics (D2NL34.SA) has reported earnings of -3.449844 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.